Using ABT-199-resistant AML cell lines derived through chronic drug exposure as amodel for acquired resistance, we identified MCL-1 and BCL-XL as keymediators of resistance, substantiating earlier findings from our pathway-activatinggenetic screen. Here, MCL1 is linked to acute myeloid leukemia.